Company
Headquarters: Copenhagen, Denmark
Employees: 3
kr514.0 Million
SEK as of July 1, 2024
US$48.4 Million
Company | Market Cap (USD) |
---|---|
Intuitive | $154.23 B |
EssilorLuxottica SA | $98.99 B |
Becton, Dickinson and Company | $65.82 B |
Alcon Inc. | $43.72 B |
HOYA Corp | $42.76 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. It develops FG001, which is in phase I/II for the treatment of high-grade glioma; and FG002 that allows surgeons to differentiate cancer from normal tissue during surgery through a novel urokinase-type plasminogen activator receptor targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was founded in 2018 and is based in Copenhagen, Denmark.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
FluoGuide A/S has the following listings and related stock indices.
Stock: OMX: FLUO wb_incandescent
Stock: FSX: 96X wb_incandescent